Flow Traders U.S.’s ARK Genomic Revolution ETF ARKG Stock Holding History

Flow Traders U.S.’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-38,002	Closed	-$1.05M	–	893
2025 Q3	$1.05M	Buy	38,002 +14,192	+60%	+$359K	0.04%	396
2025 Q2	$580K	Buy	23,810 +4,120	+21%	+$90.3K	0.02%	583
2025 Q1	$409K	Buy	+19,690	New	+$495K	0.02%	644
2024 Q1	–	Sell	-9,833	Closed	-$323K	–	793
2023 Q4	$323K	Buy	+9,833	New	+$267K	0.01%	595
2022 Q3	–	Sell	-13,254	Closed	-$417K	–	1005
2022 Q2	$417K	Buy	+13,254	New	+$463K	0.02%	535
2022 Q1	–	Sell	-5,810	Closed	-$356K	–	785
2021 Q4	$356K	Sell	5,810 -14,770	-72%	-$1.02M	0.02%	571
2021 Q3	$1.54M	Buy	+20,580	New	+$1.73M	0.06%	353
2021 Q2	–	Sell	-51,932	Closed	-$4.42M	–	934
2021 Q1	$4.61M	Buy	51,932 +33,051	+175%	+$3.28M	0.25%	73
2020 Q4	$1.76M	Sell	18,881 -4,986	-21%	-$397K	0.12%	156
2020 Q3	$1.52M	Buy	+23,867	New	+$1.4M	0.11%	175
2019 Q1	–	Sell	-13,471	Closed	-$323K	–	310
2018 Q4	$323K	Buy	+13,471	New	+$380K	0.02%	236

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Flow Traders U.S.'s ARKG Position: Q4 2025 in Review

Flow Traders U.S. sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 38,002 shares — an estimated $1.05M sold.

Flow Traders U.S. first reported a position in ARKG in Q4 2018 and held it in 11 quarters. The position peaked at $4.61M in Q1 2021. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.

Flow Traders U.S. reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
Flow Traders U.S. sold 38,002 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $1.05M.
Flow Traders U.S. first reported a position in ARK Genomic Revolution ETF in Q4 2018 and held it in 11 quarters.
Flow Traders U.S.'s ARK Genomic Revolution ETF position peaked at $4.61M in Q1 2021.
238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.

Based on Flow Traders U.S.'s 13F filing for Q4 2025, filed 13 Feb 2026.